IP Library › Granted Patent US 9,636,402
Granted Patent B2
US 9,636,402 · App. 14/711,658 · Granted May 2, 2017

Flexible and/or elastic brachytherapy seed or strand

Inventor: Edward J. Kaplan (Boca Ratan, FL)
Assignee: Microspherix LLC
A61K41/0038A61B5/064A61B90/39A61K47/48992A61K49/00A61K49/0409A61K51/1282A61L31/10A61L31/146A61L31/148A61L31/16A61L31/18A61N5/1007A61N5/1027A61B2090/3966A61L2300/44A61N2005/1023A61N2005/1024
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,636,402
App. No.
14/711,658
Granted
May 2, 2017
Kind
B2
Abstract

A flexible or elastic brachytherapy strand that includes an imaging marker and/or a therapeutic, diagnostic or prophylactic agent such as a drug in a biocompatible carrier that can be delivered to a subject upon implantation into the subject through the bore of a brachytherapy implantation needle has been developed. Strands can be formed as chains or continuous arrays of seeds up to 50 centimeters or more, with or without spacer material, flaccid, rigid, or flexible.

Claims (19)

1. A strand for administration of a therapeutic agent to a subject in need thereof comprising (a) a therapeutically effective amount of a therapeutic agent; (b) a biocompatible component comprising a polymer; (c) a radio-opaque material, wherein the radio-opaque material is encapsulated in the biocompatible component; and (d) a polymeric coating, wherein the therapeutic agent is a small molecule, wherein the polymeric coating covers the strand and wherein radiopaque material allows for the position of the strand to be determined following administration wherein the strand is non-radioactive and does not contain a radioisotope.

2. The strand of claim 1 , wherein the radio-opaque material is imageable.

3. The-strand of claim 1 , wherein the radio-opaque material comprises a high Z element.

4. The strand of claim 1 , wherein the device/strand is an implant.

5. The strand of claim 1 in the form of a rod or cylinder.

6. The strand of claim 5 , wherein the rod comprises one or more pores or cavities.

7. The strand of claim 1 , having a diameter between 0.5 and 3 mm and a length of 40 mm.

8. The strand of claim 7 , wherein the strand has a diameter of 2 mm.

9. The strand of claim 5 , wherein the rod has open ends.

10. A strand for administration of a therapeutic agent to a subject in need thereof comprising (a) a therapeutically effective amount of a therapeutic agent; (b) a biocompatible component comprising a non-biodegradable polymer; (c) a radio-opaque material, wherein the radio-opaque material is encapsulated in the biocompatible component; and (d) a polymeric coating, wherein the therapeutic agent is a small molecule and wherein the polymeric coating covers the strand, wherein the strand is non-radioactive and does not contain a radioisotope.

11. The strand of claim 1 , having a diameter between 0.8 and 3 mm and a length of 40 mm.

12. The strand of claim 1 , having a length of up to 50 cm.

13. The strand of claim 1 , wherein the strand is in the form of a rod or cylinder, and the therapeutic agent is a hormone.

14. The strand of claim 13 , having a diameter between 0.5 and 3 mm and a length of 40 mm.

15. The strand of claim 13 , wherein the therapeutic agent is not an anti-neoplastic agent.

16. A strand for administration of a therapeutic agent to a subject in need thereof comprising (a) a therapeutically effective amount of a therapeutic agent; (b) a biocompatible component comprising a polymer; (c) a radio-opaque material, wherein the radio-opaque material is encapsulated in the biocompatible component; and (d) a polymeric coating, wherein the polymeric coating covers the strand and wherein radiopaque material allows for the position of the strand to be determined following administration wherein the strand is non-radioactive and does not contain a radioisotope.

17. The strand of claim 16 , wherein the strand is in the form of a rod or cylinder, and the therapeutic agent is a hormone.

18. The strand of claim 17 , having a diameter between 0.5 and 3 mm and a length of 40 mm.

19. The strand of claim 17 , wherein the therapeutic agent is not an anti-neoplastic agent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2015
From: KAPLAN, EDWARD J.
To: MICROSPHERIX LLC
Reel/Frame 035633/0487 →
Continuity (9)
Continuation 14473159 · Aug 29, 2014
Continuation 13916916 · Jun 13, 2013
Continuation 12823700 · Jun 25, 2010
Continuation 10665793 · Sep 19, 2003
Continuation In Part 09861196 · May 18, 2001
Continuation In Part 09861326 · May 18, 2001
Provisional Application 60412050 · Sep 19, 2002
Provisional Application 60249128 · Nov 16, 2000
Related Publication 20150238661A1 · Aug 27, 2015